Product category:
Pharmaceutical Processing News
News Release from: MonoSol
Edited by the Processingtalk Editorial
Team on 20 February 2004
New pharmaceutical development Vice
President
MonoSolRx LLC today announced that Dr Pradeep Sanghvi will join the Company as its Vice President of Pharmaceutical Development, from the oral drug development company, Penwest Pharmaceuticals
MonoSolRx LLC today announced that Dr Pradeep Sanghvi will join the Company as its Vice President of Pharmaceutical Development Dr Pradeep Sanghvi is joining MonoSolRx from the oral drug development company, Penwest Pharmaceuticals, where he served as Director of Pharmaceutical Development
This article was originally published on Processingtalk on 3 Nov 2004 at 8.00am (UK)
Related stories
Water souble films around dishwasher detergent
Method Products was developing a new automatic dishwasher detergent, and turned to MonoSol, the world leader in specialty water soluble films, to help achieve improved safety in consumer handling
New water soluble film improves compatibility
MonoSol, the world leader in specialty water soluble films, introduces M-8900, a new copolymer-based polyvinyl alcohol water soluble film ideal for highly acidic and highly alkaline chemicals
Prior to Penwest, Dr Sanghvi was Director of Formulations and Process Development at the fast dissolve tablet company Fuisz Technologies, which was later acquired by Biovail.
MonoSolRx is a leading drug delivery company that uses film as a fast-dissolve oral drug delivery platform.
The MonoSolRx FDTAB film oral dosage form looks like a postage stamp and dissolves readily on the tongue to deliver drug to a patient, replacing the use of conventional tablets and capsules.
MonoSolRx also employs its proprietary film technology on a range of veterinary and nutraceutical products.
MonoSolRx was formed by MonoSol LLC, the leading producer of water soluble films.
MonoSolRx recently announced the acquisition of substantially all of the assets of the film drug delivery company, Kosmos Pharma.
MonoSolRx President and CEO P Scott Bening commented, "The selection of Dr Pradeep Sanghvi demonstrates the commitment of MonoSolRx to function as the leader, from day one, of film-based fast dissolve drug delivery.
Dr Sanghvi is an acknowledged leader in oral drug delivery and his joining MonoSolRx is excellent news for our pharmaceutical clients".
Dr Pradeep Sanghvi added, "I am thrilled to join MonoSolRx.
Their strong IP position and history of successful commercial manufacture offer a compelling value proposition to their pharmaceutical customers.
I look forward to working with the talented group at MonoSolRx combined with my oral drug delivery background to oversee the commercial launch of MonoSolRx products.
• MonoSol: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page

